Exscientia plc (0RK.SG)
| Previous close | 6.25 |
| Open | 6.35 |
| Bid | 5.50 x N/A |
| Ask | 6.40 x N/A |
| Day's range | 5.85 - 6.35 |
| 52-week range | 3.84 - 14.50 |
| Volume | |
| Avg. volume | 95 |
| Market cap | 720.796M |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.52 |
| Earnings date | 23 Mar 2023 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
Exscientia Business and Financial Update for the Full Year 2022
OXFORD, U.K., March 23, 2023--Exscientia plc (Nasdaq: EXAI)
- Business Wire
Exscientia to Report Full Year 2022 Financial Results on March 23, 2023
OXFORD, England, March 16, 2023--Exscientia plc (Nasdaq: EXAI) will report financial results for the fourth quarter and full year ended December 31, 2022 on Thursday, March 23, 2023 before the open of U.S. markets. The Company will host a conference call and webcast at 12:30 p.m. GMT / 8:30 a.m. EDT to provide a business update and review financial results.
- Business Wire
Exscientia to Present Data Highlighting Pipeline and Precision Medicine Platform at AACR
OXFORD, England, March 15, 2023--Exscientia plc (Nasdaq: EXAI) today announced that four abstracts have been accepted for poster presentation at the upcoming American Association for Cancer Research (AACR) Annual Meeting 2023, being held April 14-19, 2023, at the Orange County Convention Center in Orlando, FL. These abstracts highlight the components of Exscientia's approach to precision discovery, design and personalised medicine as well as planned innovation in the clinic.
